YUMAB announces new research & collaboration agreement with Merck

Braunschweig, July 22nd, 2019
YUMAB GmbH, a privately-held German biotechnology company, and Merck, a leading science and technology company, have signed a research and collaboration agreement on July 22nd, 2019. Within the scope of this cooperation, […] Read more